Entrada Therapeutics Inc (TRDA)

08:02 AM

What analysts say about Entrada Therapeutics Inc. stockUnmatched market gains - Autocar Professional

08:02 AM

04:30 AM

What drives Entrada Therapeutics Inc. stock priceAccelerated earnings growth - Autocar Professional

04:30 AM

03:57 AM

Is Entrada Therapeutics Inc. a good long term investmentUnmatched market gains - Autocar Professional

03:57 AM

Jul 22, 2025

How Entrada Therapeutics Inc. stock performs during market volatilityFree Stock Trading Signals - Newser

Jul 22, 2025

Jul 22, 2025

Entrada Therapeutics Inc. Stock Analysis and ForecastStrongest growth potential - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

why entrada therapeutics inc. stock attracts strong analyst attentionFree Trading Strategy Suggestions - Newser

Jul 18, 2025

Jul 15, 2025

What makes Entrada Therapeutics Inc. stock price move sharplyFree Stock Investment Growth Plan - Newser

Jul 15, 2025

Jul 15, 2025

Why Entrada Therapeutics Inc. stock attracts strong analyst attentionControlled Risk High Reward Plan - Newser

Jul 15, 2025

Jul 13, 2025

Allspring Global Investments Holdings LLC Has $149,000 Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jul 13, 2025

Jul 13, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World

Jul 13, 2025

Jul 11, 2025

Major Stock Sell-Offs at Entrada Therapeutics: What You Need to Know! - TipRanks

Jul 11, 2025

Jul 11, 2025

5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k - Investing.com Nigeria

Jul 11, 2025

Jul 11, 2025

5am Ventures v sells Entrada Therapeutics (TRDA) stock for $202k By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

Entrada therapeutics (TRDA) director Parmar sells $202k in stock By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

Entrada therapeutics (TRDA) director Parmar sells $202k in stock - Investing.com Australia

Jul 11, 2025

Jul 08, 2025

(TRDA) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 08, 2025

Jul 08, 2025

Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell? - Defense World

Jul 08, 2025

Jul 01, 2025

Entrada Therapeutics (TRDA) 10% owners sell $866k in stock - Investing.com

Jul 01, 2025

Jun 28, 2025

Entrada Therapeutics (NASDAQ:TRDA) Upgraded to “Hold” at Wall Street Zen - Defense World

Jun 28, 2025

Jun 17, 2025

(TRDA) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 17, 2025

Jun 16, 2025

Harbor Capital Advisors Inc. Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 16, 2025

Jun 14, 2025

Wall Street Zen Downgrades Entrada Therapeutics (NASDAQ:TRDA) to Sell - Defense World

Jun 14, 2025

Jun 12, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 21,594 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 12, 2025

Jun 12, 2025

Millennium Management LLC Sells 98,416 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA) - Defense World

Jun 12, 2025

Jun 11, 2025

Entrada Therapeutics Holds Virtual Annual Stockholders Meeting - TipRanks

Jun 11, 2025

Jun 10, 2025

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Holdings Raised by Bank of America Corp DE - Defense World

Jun 10, 2025

Jun 09, 2025

Transcript : Entrada Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener

Jun 09, 2025